-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Autolus Therapeutics plc quarterly/annual Revenues history and change rate from 2016 to Q1 2025.
- Autolus Therapeutics plc Revenues for the quarter ending 31 Mar 2025 was $8.98M, a 11% decline year-over-year.
- Autolus Therapeutics plc annual Revenues for 2024 was $10.1M, a 496% increase from 2023.
- Autolus Therapeutics plc annual Revenues for 2023 was $1.7M.
- Autolus Therapeutics plc annual Revenues for 2019 was $2.91M, a 107% increase from 2018.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)